其中交叉科学期刊Heliyon增幅最高,生命科学期刊Structure和医学期刊Cell Reports Medicine增幅次之。值得关注的是,中国学者在影响因子(Impact Factor,后用I)50.30分的Cancer Cell上发表的论文增幅高达160%,在One Earth、Cell Host & Microbe、Chem Catalysis等高影响力期刊上的发文量也都较上一年增加了至少1倍。 中国学...
2022 年,细胞出版社旗下 4 本期刊实现了影响力的大幅提升,其中生命科学期刊Cancer Cell影响因子(Impact Factor,后用 IF 代替)上涨幅度最高(30.36%),IF 达到 50.3;Cell Reports Physical Science涨幅次之(13.64%),最新 IF 达到 8.9。关...
Read the latest articles of Cell Reports Medicine at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
自2014年以来,他一直是威尔康奈尔医学院的医学和遗传医学教授。 最后,诚信科研部发现,Augustine M K Choi主导/参与的至少10篇Nature Medicine,Cell Reports,Lancet Respiratory Medicine,Journal of Clinical Investigation等文章被撤回。Augustine M K Choi还有其他13篇文章被质疑数据造假等问题。 Autophagy的编辑和出版商,...
Intra-tumour heterogeneity (ITH) presents a significant obstacle in formulating effective treatment strategies in clinical practice. Single-cell RNA sequencing (scRNA-seq) has evolved as a powerful instrument for probing ITH at the transcriptional level,
Lymphatic invasion (LI) is extremely aggressive and induces worse prognosis among patients with colorectal cancer (CRC). Thus, it is critical to characterize the cellular and molecular mechanisms underlying LI in order to establish novel and efficacious
Moreover, in July 2024, Stem Cell Network initiated a national research funding competition focused on regenerative medicine. This competition aims to bolster top-tier, translational research in regenerative medicine, spanning the entire research continuum, to enhance health, social, and economic outcomes...
Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension Guili Lian, Jingxian You, Weijun Lin, Gufeng Gao, Changsheng Xu, Huajun Wang & Li Luo BMC Pulmonary Medicine volume 23, Article number: 300 (2023...
Type 2 diabetes (T2D) and Clear-cell renal cell carcinoma (ccRCC) are both complicated diseases which incidence rates gradually increasing. Population based studies show that severity of ccRCC might be associated with T2D. However, so far, no researcher
One of the main roadblocks to personalized medicine of cancer is the lack of biomarkers to predict outcome and drug sensitivity from a tumour biopsy. Multigene assays such as MammaPrint1, Oncotype DX2,3and PAM504can classify Breast Cancer (BC) tumour types and risk of relapse5but with limited...